News Chart Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
477.36 ^USD	+0.90%		-1.71%	+5.29%

07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
07-20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

5.wFrKpCeK1TSfLGfxTWj4jw_afu5XUuIE5C-ew6wlsfg.jDWbyxbTrwfzZV6nFTC52T2QKKYvCoFN0nrLi8IWnLCBA6nuRsKEQ9JZJg~c52d45e51dd6cb67d877a109a8acdf77